MANDY CARTER: Open Payments
NPI 1699066969 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,465 in 78 payments from 18 companies in 2025. Trend: 2023 $1,475 · 2024 $1,242 · 2025 $1,465
Food & beverage: $1,465
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $286 |
| Insmed, Inc. | 17 | $230 |
| Regeneron Healthcare Solutions, Inc. | 12 | $225 |
| GENZYME CORPORATION | 7 | $178 |
| Novo Nordisk Inc | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
| Inspire Medical Systems, Inc. | 1 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Philips North America LLC | 2 | $34 |
| Viatris Specialty LLC | 1 | $34 |
Products named: DUPIXENT, TRELEGY ELLIPTA, Arikayce, NUCALA, INSPIRE, Wegovy, TRINTELLIX, OFEV.
Industry payments across TX — which companies pay providers there.
